| Similar Articles |
|---|
 |
Chemistry World
June 8, 2015
Rebecca Trager |
NIH drug manufacturing unit shut down The halt could potentially affect 46 clinical trials, and about 250 patients who are either receiving, or about to receive, products manufactured at the facility.   |
Information Today
June 16, 2015 |
NIH Plans for the Future of the National Library of Medicine The National Institutes of Health's director, Francis S. Collins, approved the proposed strategic plan for the National Library of Medicine. |
Pharmaceutical Executive
February 1, 2011
Jill Wechsler |
The Building Block of Drug Discovery With Francis Collins now calling the shots at NIH, will be be able to deliver on the innovations behind the genome? |
Reason
June 2005
Kerry Howley |
Scientists for Sale Innovation vs. ethics: Scientists at the NIH have discovered many things over the years, but evidently they haven't yet found a way to balance innovation and objectivity. |
Chemistry World
October 10, 2014
Rebecca Trager |
US ramps up rare diseases research The US National Institutes of Health is spending $29 million to fund research consortia that will study more than 200 rare diseases. |
Chemistry World
February 6, 2015
Rebecca Trager |
US funder mulls new emeritus award The US National Institutes of Health is exploring a new grant mechanism for emeritus faculty that would let senior investigators exit their NIH research grant supported role. |
D-Lib
September 2004
Bonita Wilson |
Recommended Reading For the D-Lib audience: US Congressional Budget Office report, Copyright Issues in Digital Media... UK House of Commons Science and Technology Committee report, Scientific Publications: Free for All?... National Institutes of Health (NIH) publication Notice: Enhanced Public Access to NIH Research Information... |
Pharmaceutical Executive
January 1, 2006
Clinton & Wechsler |
What Ever Happened to Critical Path FDA's ambitious program to improve drug development disappeared from view almost as soon as it was announced. Suddenly, it's back, but is it here to stay? |
Pharmaceutical Executive
April 1, 2012
Jill Wechsler |
Shortages and Sunshine Disclosure rules the day, as industry confronts demands to report supply problems, results of clinical trials, and payment to doctors. |
Bio-IT World
April 15, 2003
Janet Woodcock |
FDA Director Explains the Changes The head of the Center for Drug Evaluation and Research discusses why the FDA is now kinder and gentler about Part 11 compliance. |
The Motley Fool
November 15, 2007
Brian Orelli |
John Edwards' Not-So-Bad Plan John Edwards' plan to take away drug patents in exchange for a monetary price just may work, if the price is high enough. |
Chemistry World
June 11, 2015
Rebecca Trager |
US spends billions annually on unreproducible preclinical research Preclinical research that can't be replicated is funded to the tune of about $28 billion in the US annually. |
American Family Physician
October 1, 2000
Rosemarie Sweeney & Toni Lapp |
Newsletter Report Highlights What Older Americans Think About Medicare... $35,000 Grant Paves Way for Tool to Prevent Prescription Errors... FDA Launches Oncology Tools Web Site... Federal Funds Support Research in Women's Health... Surgeon General's Report on Tobacco Use Draws AMA Approval... |
Geotimes
November 2004 |
Open Access: Open Debate? Imagine any U.S. citizen having free and open access to research funded with tax dollars. That possibility could be closer to reality than ever before, but Congress must first address some important concerns |
Chemistry World
June 2, 2015
Rebecca Trager |
NIH-funded principal investigators fell sharply in 2010 A former senior leader at the US National Institutes of Health has found what he calls a 'startling' decline in the number of principal investigators funded by the agency from between 2010 and the present day. |
Bio-IT World
January 21, 2005
Jim Golden |
Top 10 Trends for 2005 Pharmacovigilance, compliance, outsourcing, and the CIO's role will be big this year. |
Pharmaceutical Executive
June 1, 2012
Jill Wechsler |
Innovation and Collaboration A rash of "pro-innovative" approaches for testing and regulating medical products offer ways to speed more new products to market. |
Pharmaceutical Executive
September 1, 2013
Jill Wechsler |
Biopharma Innovation in Trouble? Regulators, sponsors seek more productive research strategies. |
Pharmaceutical Executive
May 1, 2009
Jill Wechsler |
Compared to What? Pharma fears comparative effectiveness research will focus on costs and stymie personalized medicine. |
Chemistry World
August 4, 2008
Pete Mitchell |
Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate. |
The Motley Fool
August 14, 2007
Brian Orelli |
Drugmaker Growth Without the FDA Do you have one of those stomachs that just can't take the ups and downs of clinical trial data and FDA approval decisions? Buy stocks in the companies that support the drug makers. |
Chemistry World
January 22, 2008
Rebecca Trager |
NIH Battles Publishers Over Open Access The NIH has published controversial new rules that is sparking a showdown with publishers, including the American Chemical Society. |
Chemistry World
May 19, 2010
Rebecca Trager |
NIH spends $1 billion on research construction projects The US National Institutes of Health has awarded $1 billion ( 700 million) to universities and medical centers across the country for the construction or upgrading of scientific research laboratories. |
Pharmaceutical Executive
January 1, 2012
Jill Wechsler |
New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation. |
ifeminists
July 1, 2003
Carey Roberts |
Taxpayers Bankroll Feminist Hoax To this day, officials from the NIH Office of Research on Women's Health continue to spin the claim that women were shortchanged by medical research. |
Chemistry World
March 1, 2010
Rebecca Trager |
US launches new regulatory science program Two major US government agencies have partnered to create a new regulatory science program to ensure better integration between cutting edge science and regulatory processes in assessing new medical products or compounds flowing from biomedical research. |
Pharmaceutical Executive
October 1, 2011
Jill Wechsler |
Guiding a Revolution in Science Francis Collins led the genomic revolution as director of the International Human Genome Project and director of the National Human Genome Research Institute (NHGRI) at the NIH from 1993 to 2008. |
Information Today
September 13, 2004
Barbara Quint |
NIH Requires Open Access for Its Funded Medical Research With the NIH's decision, the fast-paced open access movement has picked up even more momentum. |
Chemistry World
September 14, 2015
Rebecca Trager |
NIH backs natural products research The US National Institutes of Health has awarded nearly $35 million to fund research into botanical dietary supplements. |
Pharmaceutical Executive
May 1, 2005
Jill Wechsler |
Washington Report: The Pendulum Swings FDA cracks down on safety. Haven't we been here before? Perhaps in the end, the public will have a better understanding of the dangers associated with all pharmaceuticals and how virtually impossible it is to guarantee a risk-free medical treatment. |
Chemistry World
September 18, 2008
James Mitchell Crow |
Ranbaxy hit by US drug ban The US Food and Drug Administration (FDA) has banned the import of more than 30 drugs made by Ranbaxy, India's largest drugmaker. |
Chemistry World
December 19, 2011
Rebecca Trager |
US agencies collaborate to test 10,000 chemicals A high-speed robotic screening system jointly initiated by three key US health agencies began testing more than 10,000 chemical compounds for potential toxicity on 7 December. |
Pharmaceutical Executive
June 1, 2005
Peter J. Pitts |
Opinion: Uncle Sam, MD Is having the government pursue a patent the best way of placing important discoveries in the public domain? It depends. Is putting the government in control of drug development in the best interests of public health? No. |
ifeminists
May 27, 2003
Carey Roberts |
Unfit to Print: Case Study in Deceit at the New York Times This is the account of a fact-finding study that was issued by a governmental agency, how the New York Times grossly misreported the study, and how the myth nurtured by the NYT story ultimately influenced the federal legislative process. |
Chemistry World
October 3, 2014
Rebecca Trager |
US research agencies in limbo Congress adjourned in September to campaign for the mid-term elections without passing a budget for any federal agency, and won't return to work until 12 November. |
